Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
China Evergrande New Energy Vehicle Group Limited (EVGRF)
Guangzhou, CN
China Evergrande New Energy Vehicle Group Limited, an investment holding entity, conducts its diverse business operations across the People's Republic of China, Europe, and on an international scale. The enterprise is strategically structured into two main divisions: Health Management and New Energy Vehicle. Under its Health Management segment, the company is involved in the creation and sale of health-focused living properties. It also delivers a range of services, including comprehensive community health programs, advanced medical cosmetology, anti-aging therapies, and extensive elderly care and rehabilitation. Additionally, this division handles the wholesale distribution of home care and various healthcare products, offers healthcare services, and provides software solutions. Its scope further extends to pharmaceutical research and development, along with the production of medical equipment. The New Energy Vehicle division focuses on the research, development, manufacturing, and marketing of new energy vehicles, alongside related vehicle living initiatives. This segment also covers the production and sale of smart mobility products and lithium-ion batteries. Originally founded in 1999 as Evergrande Health Industry Group Limited, the company re-branded to China Evergrande New Energy Vehicle Group Limited in August 2020. Headquartered in Guangzhou, China, it operates as a subsidiary of the China Evergrande Group.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | -81.82% | -81.82% | -75.00% | -81.82% | -98.67% | +0.00% | -100.00% | -100.00% | -100.00% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
-
Revenue growth Medical - Care Facilities: +10.2%+900.0% ★ Q2'24: -99.7% (vs Q2'22)
-
EPS growth Medical - Care Facilities: +19.2%+19.7% ★ Q2'24: -218.1% (vs Q2'22)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%-582.9% Q2'24: -258.6% (vs Q2'22)
-
EBIT margin Medical - Care Facilities: +11.3%-673.9% Q2'24: -334,641.2% (vs Q2'22)
-
ROIC Medical - Care Facilities: +6.8%— Q2'24: +229.2% (vs Q2'22)
-
Share dilution Medical - Care Facilities: +0.0%+0.0% Q2'24: +0.0% (vs Q2'22)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×-3.40× Q2'24: -0.38× (vs Q2'22)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Wai Hong Choi | Executive Director | 186.4K | male |
| Shawn Siu | Executive Chairman | 27.9K | male |
| Darong Pan | Chief Financial Officer | — | male |
| Gao Jingshen | Executive President of Evergrande New Energy Automobile Group | — | male |
| Kar Chun Fong | Company Secretary | — | male |
| Yi Yang | President of Boao Evergrande International Hospital | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for EVGRF
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
